Shares of Thermo Fisher Scientific Inc. TMO slid 0.28% to $534.36 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.82% to 6 ...

The global Radiotherapy market is expected to grow to USD 9.62 Billion by 2030, up from USD 7.21 Billion in 2024, at a CAGR ...

Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Krishna ...

Four Latvian companies have been included in the “Top 30” list of most valuable Baltic businesses, according to the list ...

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a ...

The stock's fall snapped a two-day winning streak.

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical ...

Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with ...

The Thermo Fisher Scientific Junior Innovators Challenge engages 65-thousand middle school students annually through affiliate science and engineering fairs nationwide. Tina ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $537.23 which represents a slight increase of $7.87 or 1.49% from the prior close of $529.36. The stock opened at ...

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

The global cell culture market is estimated to flourish at a CAGR of 9% from 2021 to 2031. Transparency Market Research projects that the overall sales revenue for cell culture is estimated to reach ...